These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2879504)

  • 1. [Current therapeutic concepts in the treatment of myocardial ischemia. Current and future drugs].
    Jaillon P
    Ann Cardiol Angeiol (Paris); 1986 Oct; 35(7 Pt 2):453-8. PubMed ID: 2879504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of angina pectoris. New perspectives].
    Jaillon P
    Presse Med; 1986 Oct; 15(35):1747-53. PubMed ID: 2947145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive drug management of angina pectoris.
    Pepine CJ; Feldman RL; Conti CR
    Cardiovasc Clin; 1984; 14(3):139-51. PubMed ID: 6144388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of anti-ischemia treatment in man].
    Dupuis B; Vincent A; Lablanche JM
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():73-6. PubMed ID: 2895620
    [No Abstract]   [Full Text] [Related]  

  • 7. Free radicals and myocardial ischemia and reperfusion injury.
    Simpson PJ; Lucchesi BR
    J Lab Clin Med; 1987 Jul; 110(1):13-30. PubMed ID: 3298506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
    Willerson JT; Buja LM
    Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of myocardial ischaemia and the prevention of necrosis.
    Taylor RR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288
    [No Abstract]   [Full Text] [Related]  

  • 10. A pathophysiologic basis for the clinical classification and management of unstable angina.
    Théroux P
    Circulation; 1987 Jun; 75(6 Pt 2):V103-9. PubMed ID: 2882869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.
    Frishman WH
    Circulation; 1983 Jun; 67(6 Pt 2):I11-8. PubMed ID: 6133640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins and heart disease.
    Beamish RE; Das PK; Karmazyn M; Dhalla NS
    Can J Cardiol; 1985 Jan; 1(1):66-74. PubMed ID: 3850765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unstable angina: recent findings and therapeutic applications].
    Daune M; Quarre JP; Michalakis G; Courtoy JF
    Rev Med Brux; 1987 May; 8(5):265-73. PubMed ID: 2887025
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelets, endothelium, and vessel injury.
    Mustard JF; Kinlough-Rathbone RL; Packham MA
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():235-45. PubMed ID: 3159207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of medications on myocardial perfusion.
    Zoghbi GJ; Dorfman TA; Iskandrian AE
    J Am Coll Cardiol; 2008 Aug; 52(6):401-16. PubMed ID: 18672159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered metabolism of thromboxane A2 and prostacyclin in the pathogenesis of coronary vasospasm and thrombosis.
    Tada M; Kuzuya T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():481-4. PubMed ID: 2936148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is preferable in unstable angina, beta-blockade or calcium-inhibition?
    Hugenholtz PG; Serruys PW; Simoons ML
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():199-209. PubMed ID: 6134510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists in the treatment of coronary heart disease].
    Rafflenbeul W
    Fortschr Med; 1984 Jul; 102(27-28):718-21. PubMed ID: 6479814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.